57 related articles for article (PubMed ID: 30913090)
1. Treatment patterns for hepatocellular carcinoma in patients with Child-Pugh class B and their impact on survival: A Korean nationwide registry study.
Jeon D; Song GW; Lee HC; Shim JH
Liver Int; 2022 Dec; 42(12):2830-2842. PubMed ID: 36287103
[TBL] [Abstract][Full Text] [Related]
2. Management of patients with intermediate stage hepatocellular carcinoma.
Prince D; Liu K; Xu W; Chen M; Sun JY; Lu XJ; Ji J
Ther Adv Med Oncol; 2020; 12():1758835920970840. PubMed ID: 33224278
[TBL] [Abstract][Full Text] [Related]
3. Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy.
Ielasi L; Stefanini B; Conti F; Tonnini M; Tortora R; Magini G; Sacco R; Pressiani T; Trevisani F; Foschi FG; Piscaglia F; Granito A; Tovoli F
Curr Oncol; 2024 Jan; 31(1):547-557. PubMed ID: 38275831
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?
Adhoute X; Penaranda G; Castellani P; Perrier H; Bourliere M
World J Hepatol; 2015 Mar; 7(3):521-31. PubMed ID: 25848475
[TBL] [Abstract][Full Text] [Related]
5. Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance.
Johnson P; Berhane S; Kagebayashi C; Satomura S; Teng M; Fox R; Yeo W; Mo F; Lai P; Chan SL; Tada T; Toyoda H; Kumada T
Br J Cancer; 2017 Feb; 116(4):441-447. PubMed ID: 28081537
[TBL] [Abstract][Full Text] [Related]
6. Classification of hepatocellular carcinoma stages from free-text clinical and radiology reports.
Yim WW; Kwan SW; Johnson G; Yetisgen M
AMIA Annu Symp Proc; 2017; 2017():1858-1867. PubMed ID: 29854257
[TBL] [Abstract][Full Text] [Related]
7. Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular Carcinoma.
Jihye C; Jinsil S
Liver Cancer; 2012 Nov; 1(3-4):216-25. PubMed ID: 24159586
[TBL] [Abstract][Full Text] [Related]
8. A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma.
Han JW; Lee SK; Kwon JH; Nam SW; Yang H; Bae SH; Kim JH; Nam H; Kim CW; Lee HL; Kim HY; Lee SW; Lee A; Chang UI; Song DS; Kim SH; Song MJ; Sung PS; Choi JY; Yoon SK; Jang JW
Clin Cancer Res; 2024 Apr; ():. PubMed ID: 38639918
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Brustia R; Bouattour M; Allaire M; Lequoy M; Hollande C; Regnault H; Blaise L; Ganne-Carrié N; Vilgrain V; Larrey E; Lim C; Scatton O; Mouhadi SE; Ozenne V; Paye F; Balladur P; Dohan A; Massault PP; Pol S; Dioguardi Burgio M; Sepulveda A; Cauchy F; Luciani A; Sommacale D; Leroy V; Calderaro J; Roudot-Thoraval F; Nault JC; Amaddeo G;
Ann Hepatol; 2023; 28(6):101141. PubMed ID: 37468096
[TBL] [Abstract][Full Text] [Related]
10. Adherence to Tumor Board Recommendations in the Treatment of Patients with Hepatocellular Carcinoma.
Cao Y; Mezzacappa C; Jaffe A; Strazzabosco M; Taddei TH
J Multidiscip Healthc; 2023; 16():1531-1540. PubMed ID: 37283950
[TBL] [Abstract][Full Text] [Related]
11. Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm?
Stefanini B; Ielasi L; Pallotta DP; Penazza S; Marseglia M; Piscaglia F
J Liver Cancer; 2024 Mar; 24(1):23-32. PubMed ID: 38468499
[TBL] [Abstract][Full Text] [Related]
12. Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study.
De Souza S; Kahol de Jong J; Perone Y; Shetty S; Qurashi M; Vithayathil M; Shah T; Ross P; Temperley L; Yip VS; Banerjee A; Bettinger D; Sturm L; Reeves HL; Geh D; Orr J; Allen B; Jones RP; Sharma R
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444488
[TBL] [Abstract][Full Text] [Related]
13. Biologics, Immunotherapies, and Cytotoxic Chemotherapy for Hepatocellular Carcinoma following Current Recommendations by the BCLC: A Review of Agents.
Gurtatta RS; Whalen SE; Ray CE
Semin Intervent Radiol; 2024 Feb; 41(1):84-91. PubMed ID: 38495256
[No Abstract] [Full Text] [Related]
14. Evidence and Choice: The BCLC Vision for Tailoring Clinical Decision-Making.
Reig M; Forner A; Rimola J; Ferrer-Fàbrega J; Burrel M; Garcia-Criado Á; Kelley RK; Galle PR; Mazzaferro V; Salem R; Sangro B; Singal AG; Vogel A; Fuster J; Ayuso C; Bruix J
J Hepatol; 2024 May; ():. PubMed ID: 38729354
[No Abstract] [Full Text] [Related]
15. Patients with Barcelona Clinic Liver Cancer Stages B and C Hepatocellular Carcinoma: Time for a Subclassification.
Golfieri R; Bargellini I; Spreafico C; Trevisani F
Liver Cancer; 2019 Mar; 8(2):78-91. PubMed ID: 31019899
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence in assessment of hepatocellular carcinoma treatment response.
Spieler B; Sabottke C; Moawad AW; Gabr AM; Bashir MR; Do RKG; Yaghmai V; Rozenberg R; Gerena M; Yacoub J; Elsayes KM
Abdom Radiol (NY); 2021 Aug; 46(8):3660-3671. PubMed ID: 33786653
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma staging systems: Hong Kong liver cancer
de Freitas LBR; Longo L; Santos D; Grivicich I; Álvares-da-Silva MR
World J Hepatol; 2019 Sep; 11(9):678-688. PubMed ID: 31602288
[TBL] [Abstract][Full Text] [Related]
18. BCLC-B Subclassification and the Hong Kong Liver Cancer System in Intermediate Hepatocellular Carcinoma: Identifying Candidates for Curative Therapy.
Longo L; Rodrigues de Freitas LB; Santos D; Grivicich I; Álvares-da-Silva MR
Am J Clin Oncol; 2019 May; 42(5):466-471. PubMed ID: 30913090
[TBL] [Abstract][Full Text] [Related]
19. Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective.
Li JW; Goh BG; Chang PE; Tan CK
World J Gastroenterol; 2017 Jun; 23(22):4054-4063. PubMed ID: 28652658
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
